Kimba Adds Industry Veteran to Leadership Team as Vice President of Customer Success
Jun 14, 2016 12:10 pm UTC| Business
AUSTIN, TEXAS, June 14, 2016 -- Kimbia, a leading provider of online fundraising solutions and crowdfunding events, announced today the addition of Tori Jordan to its leadership team. As the Vice President of Customer...
Jun 14, 2016 11:48 am UTC| Business
TORONTO, June 14, 2016 -- Electrovaya Inc. (TSX:EFL) today announced that its fully owned subsidiary Litarion GmbH signed a Memorandum of Understanding (MOU) with a leading European battery OEM who designs and integrates...
Auriemma Consulting Group Joins the Merchant Advisory Group as a Silver Sponsor
Jun 14, 2016 11:47 am UTC| Business
NEW YORK, June 14, 2016 -- Auriemma Consulting Group is pleased to announce it is now a Silver Sponsor of the Merchant Advisory Group (MAG). Support for the MAG is the latest development in ACG's lengthy history of...
Auris Medical Hosts Key Opinion Leader Event Focused on Phase 3 Program for Acute Inner Ear Tinnitus
Jun 14, 2016 11:32 am UTC| Business
Company introduces KeyzilenTM as brand name for AM-101 KeyzilenTM has potential to be first-ever approved therapy for tinnitus Live webcast of event begins today at 8 am EDT ZUG, Switzerland, June 14, 2016 --...
Dr. Ronald Lehman is first in NYC to Perform PROlat(TM) Procedure with Mazor Robotics Technology
Jun 14, 2016 08:38 am UTC| Business
ORLANDO, Fla., June 14, 2016 -- Mazor Robotics, a developer of innovative surgical guidance systems and complementary products, today announced that Dr. Ronald Lehman was the first in New York City to perform a...
Wolters Kluwer Update on Share Buyback Program
Jun 14, 2016 06:06 am UTC| Business
ALPHEN AAN DEN RIJN, Netherlands, June 14, 2016 -- Wolters Kluwer, a global leader in professional information services and solutions, announces that, so far this year, it has repurchased 0.8 million ordinary shares for a...
Targovax granted US Patent for oncolytic virus ONCOS-102
Jun 14, 2016 06:05 am UTC| Business
OSLO, Norway, June 14, 2016 -- Targovax announced today that the US Patent and Trademark office has granted US patent no 9,345,787 for Targovax' lead viral product ONCOS-102. ONCOS-102 is a purposefully engineered human...